Aura Biosciences (AURA) Total Liabilities (2020 - 2026)

Aura Biosciences has reported Total Liabilities for 7 years, with the latest figure at $30.4 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 10.92% year-over-year to $30.4 million; the trailing twelve-month figure through Mar 2026 stood at $30.4 million (up 10.92% YoY), and the FY2025 full-year result was $32.5 million, up 6.5% from the prior year.
• Total Liabilities for Q1 2026 stood at $30.4 million, down from $32.5 million in the prior quarter.
• The five-year high for Total Liabilities was $33.4 million in Q3 2025, with the low at $5.3 million in Q1 2022.
• Historically, Total Liabilities has averaged $26.2 million across 5 years, with a median of $28.1 million in 2022.
• Annual changes were most pronounced in 2022 — Total Liabilities slumped 95.33% — and 2023, when it jumped 382.78%.
• Aura Biosciences' Total Liabilities stood at $28.4 million in 2022, then climbed by 3.09% to $29.2 million in 2023, then advanced by 4.47% to $30.5 million in 2024, then climbed by 6.5% to $32.5 million in 2025, then dropped by 6.42% to $30.4 million in 2026.
• The last three Total Liabilities figures came in at $30.4 million (Q1 2026), $32.5 million (Q4 2025), and $33.4 million (Q3 2025), per Business Quant data.